Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SDZ281-977 (SDZ-LAP 977) is a derivative of Lavendustin A. It exhibits anticancer and antiplusative activity and inhibits the growth of human vulvar cancer cells.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 23,000 | |||
5 mg | 在庫あり | ¥ 57,000 | |||
10 mg | 在庫あり | ¥ 91,000 | |||
25 mg | 在庫あり | ¥ 182,000 | |||
50 mg | 在庫あり | ¥ 282,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 62,500 |
説明 | SDZ281-977 (SDZ-LAP 977) is a derivative of Lavendustin A. It exhibits anticancer and antiplusative activity and inhibits the growth of human vulvar cancer cells. |
In vitro | SDZ 281-977 significantly inhibits the proliferation of human pancreatic tumor cells MIA PaCa-2 and human vulvar carcinoma cells A431 at low micromolar levels[1]. |
In vivo | SDZ 281-977 (30 mg/kg; PO; 3 weeks) significantly inhibits the growth of A431 tumors[1]. |
別名 | SDZ-LAP 977 |
分子量 | 316.35 |
分子式 | C18H20O5 |
CAS No. | 150779-71-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 80 mg/mL (252.88 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SDZ281-977 150779-71-8 Angiogenesis JAK/STAT signaling Tyrosine Kinase/Adaptors EGFR SDZ-281-977 SDZ281977 SDZ-LAP977 SDZ281 977 SDZ-LAP-977 SDZ-LAP 977 Inhibitor inhibitor inhibit